Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Year-over-year operating income growth rate
Latest
8.54%
↑ 163% vs avg
Percentile
P74
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-13.58%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 8.54% |
| Q3 2025 | -23.45% |
| Q2 2025 | 36.16% |
| Q1 2025 | 14.07% |
| Q4 2024 | -6.69% |
| Q3 2024 | 70.92% |
| Q2 2024 | -117.95% |
| Q1 2024 | 16.38% |
| Q4 2023 | -92.66% |
| Q3 2023 | -10.86% |
| Q2 2023 | 5.55% |
| Q1 2023 | -23.28% |
| Q4 2022 | -18.32% |
| Q3 2022 | 13.28% |
| Q2 2022 | -19.23% |
| Q1 2022 | -49.54% |
| Q4 2021 | -3.21% |
| Q3 2021 | 5.05% |
| Q2 2021 | -6.70% |
| Q1 2021 | -8.48% |
| Q4 2020 | -9.96% |
| Q3 2020 | 9.37% |
| Q2 2020 | 2.52% |
| Q1 2020 | -7.03% |
| Q4 2019 | -26.11% |
| Q3 2019 | -23.07% |
| Q2 2019 | -193.49% |
| Q1 2019 | 11.51% |
| Q4 2018 | 0.00% |
| Q2 2018 | 25.00% |
| Q1 2018 | -12.79% |
| Q4 2017 | 0.00% |